EP-027315

N/A

Report date: 2023/05/22 10:17:14
NME

Base Information

Drug NameEP-027315
Drug Alias NameEP-027315
ClassificationSmall molecules
Mechanisms of ActionMAP kinase-activated protein kinase 5 inhibitors
TargetsMAP kinase-activated protein kinase 5
Therapy Area/IndicationsMetabolic DiseasesLiver Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEnanta Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesEnanta Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsMetabolic DiseasesLiver Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A